Page last updated: 2024-10-23

bunazosin and Myocarditis

bunazosin has been researched along with Myocarditis in 2 studies

bunazosin: structure

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research Excerpts

ExcerptRelevanceReference
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."7.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)
"The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis."7.68The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992)
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."3.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)
"The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis."3.68The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yue-Chun, L1
Li-Sha, G1
Jiang-Hua, R1
Peng-Lin, Y1
Jia-Feng, L1
Ji-Fei, T1
Peng, C1
Zhan-Qiu, Y1
Yamada, T1
Matsumori, A1
Okada, I1
Tominaga, M1
Kawai, C1

Other Studies

2 other studies available for bunazosin and Myocarditis

ArticleYear
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo

2008
The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
    Japanese circulation journal, 1992, Volume: 56, Issue:11

    Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Encephalomyocarditis virus; Enterovir

1992